Aspaveli® (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
STOCKHOLM, Oct. 15, 2021 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announce today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion…
Comments Off on Aspaveli® (pegcetacoplan) receives positive CHMP opinion for treatment of PNH